Calcola online lo stadio EASL - BCLC dell'Epatocarcinoma

Stadio e terapia dell'HCC

In questa pagina puoi calcolare lo stadio dell’epatocarcinoma di un singolo paziente secondo la modificazione alla Classificazione di Barcellona (BCLC) comparsa nelle Linee Guida dell’EASL (EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019.)

La stadiazione offre anche la scelta della terapia più indicata per lo stadio di malattia.

Il sistema BCLC è stato nuovamente aggiornato nel marzo 2022. Puoi consultare il nuovo schema ed usare il nuovo calcolatore seguendo il link.

In fondo alla pagina puoi trovare la referenza bibliografica ed il link per questa e per le altre linee guida per la diagnosi ed il trattamento dell’epatocarcinoma,

Schema originale della Classificazione EASL BCLC

Calcolatori Online

Usa gli altri calcolatori online per fegato e pancreas

Epatocarcinoma

Diagnosi e terapia dell'epatocarcinoma

BCLC

Classificazione prognostica dell'epatocarcinoma

Linee Guida per la Diagnosi ed il Trattamento dell'Epatocarcinoma

16 dati « 1 di 2 »

2023

Singal A G; Llovet J M; Yarchoan M; Mehta N; Heimbach J K; Dawson L A; Jou J H; Kulik L M; Agopian V G; Marrero J A; Mendiratta-Lala M; Brown D B; Rilling W S; Goyal L; Wei A C; Taddei T H

AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma Journal Article

In: Hepatology, 2023.

Links | BibTeX

Borzio M; Cabibbo G; Gardini A C; Cillo U; Colli A; Conforti M; Dadduzio V; Daniele B; Dionisi F; Farinati F; Gardini I; Giannini E G; Golfieri R; Guido M; Mega A; Piscaglia F; Rimassa L; Romanini L; Pecorelli A; Sacco R; Scorsetti M; Trevisani F; Viganò L; Vitale A; Cinquini M; Minozzi S; Monteforte M; Fittipaldo V A

Gestione multidisciplinare del paziente con epatocarcinoma. Working paper

2023, (La LG ha superato la valutazione con AGREE II; se ne raccomanda l'utilizzo.).

Links | BibTeX

2022

Su G L; Altayar O; O'Shea R; Shah R; Estfan B; Wenzell C; Sultan S; Falck-Ytter Y

AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma Journal Article

In: Gastroenterology, vol. 162, no 3, pp. 920 – 934, 2022, ISSN: 00165085, (Cited by: 7; All Open Access, Bronze Open Access).

Abstract | Links | BibTeX

Reig M; Forner A; Rimola J; Ferrer-Fàbrega J; Burrel M; Garcia-Criado Á; Kelley R K; Galle P R; Mazzaferro V; Salem R; Sangro B; Singal A G; Vogel A; Fuster J; Ayuso C; Bruix J

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update Journal Article

In: Journal of Hepatology, vol. 76, no 3, pp. 681 – 693, 2022, ISSN: 01688278, (Cited by: 118; All Open Access, Bronze Open Access).

Abstract | Links | BibTeX

Sun J; Guo R; Bi X; Wu M; Tang Z; Lau W Y; Zheng S; Wang X; Yu J; Chen X; Fan J; Dong J; Chen Y; Cui Y; Dai C; Fang C; Feng S; Ji Z; Jia W; Jia N; Li G; Li J; Li Q; Li J; Liang T; Liu L; Lu S; Lv Y; Mao Y; Meng Y; Meng Z; Shen F; Shi J; Sun H; Tao K; Teng G; Wan X; Wen T; Wu L; Xia J; Ying M; Zhai J; Zhang L; Zhang X; Zhang Z; Zhao H; Zheng D; Zhi X; Zhou J; Zhou C; Zhou J; Zeng Z; Zhu K; Chen M; Cai J; Cheng S

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) Journal Article

In: Liver Cancer, vol. 11, no 4, pp. 315 – 328, 2022, ISSN: 22351795, (Cited by: 0; All Open Access, Gold Open Access, Green Open Access).

Abstract | Links | BibTeX

Park J

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma Journal Article

In: Clinical and Molecular Hepatology, vol. 28, no 4, pp. 583 – 705, 2022, ISSN: 22872728, (Cited by: 0; All Open Access, Gold Open Access, Green Open Access).

Abstract | Links | BibTeX

2021

Vogel A; Martinelli E; Cervantes A; Chau I; Daniele B; Llovet J M; Meyer T; Nault J -C; Neumann U; Ricke J; Sangro B; Schirmacher P; Verslype C; Zech C J; Arnold D

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines Journal Article

In: Annals of Oncology, vol. 32, no 6, pp. 801 – 805, 2021, ISSN: 09237534, (Cited by: 70; All Open Access, Bronze Open Access).

Links | BibTeX

Kudo M; Kawamura Y; Hasegawa K; Tateishi R; Kariyama K; Shiina S; Toyoda H; Imai Y; Hiraoka A; Ikeda M; Izumi N; Moriguchi M; Ogasawara S; Minami Y; Ueshima K; Murakami T; Miyayama S; Nakashima O; Yano H; Sakamoto M; Hatano E; Shimada M; Kokudo N; Mochida S; Takehara T

Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update Journal Article

In: Liver Cancer, vol. 10, no 3, pp. 181 – 223, 2021, ISSN: 22351795, (Cited by: 61; All Open Access, Gold Open Access, Green Open Access).

Abstract | Links | BibTeX

III A B B; D'Angelica M I; Abbott D E; Anaya D A; Anders R; Are C; Bachini M; Borad M; Brown D; Burgoyne A; Chahal P; Chang D T; Cloyd J; Covey A M; Glazer E S; Goyal L; Hawkins W G; Iyer R; Jacob R; Kelley R K; Kim R; Levine M; Palta M; Park J O; Raman S; Reddy S; Sahai V; Schefter T; Singh G; Stein S; Vauthey J; Venook A P; Yopp A; McMillian N R; Hochstetler C; Darlow S D

Hepatobiliary cancers, Version 2.2021 Journal Article

In: JNCCN Journal of the National Comprehensive Cancer Network, vol. 19, no 5, pp. 541 – 565, 2021, ISSN: 15401405, (Cited by: 234; All Open Access, Bronze Open Access).

Abstract | Links | BibTeX

2020

Zhou J; Sun H; Wang Z; Cong W; Wang J; Zeng M; Zhou W; Bie P; Liu L; Wen T; Han G; Wang M; Liu R; Lu L; Ren Z; Chen M; Zeng Z; Liang P; Liang C; Chen M; Yan F; Wang W; Ji Y; Yun J; Cai D; Chen Y; Cheng W; Cheng S; Dai C; Guo W; Hua B; Huang X; Jia W; Li Y; Li Y; Liang J; Liu T; Lv G; Mao Y; Peng T; Ren W; Shi H; Shi G; Tao K; Wang W; Wang X; Wang Z; Xiang B; Xing B; Xu J; Yang J; Yang J; Yang Y; Yang Y; Ye S; Yin Z; Zhang B; Zhang B; Zhang L; Zhang S; Zhang T; Zhao Y; Zheng H; Zhu J; Zhu K; Liu R; Shi Y; Xiao Y; Dai Z; Teng G; Cai J; Wang W; Cai X; Li Q; Shen F; Qin S; Dong J; Fan J

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) Journal Article

In: Liver Cancer, vol. 9, no 6, pp. 682 – 720, 2020, ISSN: 22351795, (Cited by: 131; All Open Access, Gold Open Access, Green Open Access).

Abstract | Links | BibTeX

2018

Galle P R; Forner A; Llovet J M; Mazzaferro V; Piscaglia F; Raoul J; Schirmacher P; Vilgrain V

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma Journal Article

In: Journal of Hepatology, vol. 69, no 1, pp. 182 – 236, 2018, ISSN: 01688278, (Cited by: 3579; All Open Access, Hybrid Gold Open Access).

Links | BibTeX

Marrero J A; Kulik L M; Sirlin C B; Zhu A X; Finn R S; Abecassis M M; Roberts L R; Heimbach J K

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases Journal Article

In: Hepatology, vol. 68, no 2, pp. 723 – 750, 2018, ISSN: 02709139, (Cited by: 1758; All Open Access, Bronze Open Access).

Links | BibTeX

Vogel A; Cervantes A; Chau I; Daniele B; Llovet J; Meyer T; Nault J -C; Neumann U; Ricke J; Sangro B; Schirmacher P; Verslype C; Zech C J; Arnold D; Martinelli E

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Journal Article

In: Annals of Oncology, vol. 29, pp. iv238 – iv255, 2018, ISSN: 09237534, (Cited by: 385; All Open Access, Green Open Access, Hybrid Gold Open Access).

Links | BibTeX

2016

per lo Studio del Fegato (AISF) A I; di Oncologia Medica (AIOM) A I; International Hepato-PancreatoBiliaryAssociation I; di Chirurgia (SIC) S I; di Radiologia Medica ed Interventistica (SIRM) S I; d’Organo (SITO) S I T

Raccomandazioni Multisocietarie Italiane (AISF, AIOM, IT‐IHPBA, SIC, SIRM, SITO) per la gestione clinica integrata del paziente con Epatocarcinoma Working paper

2016.

Links | BibTeX

2003

Ryder S D

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults Journal Article

In: Gut, vol. 52, no SUPPL. 3, pp. iii1–iii8, 2003, ISSN: 00175749, (Cited by: 349; All Open Access, Bronze Open Access, Green Open Access).

Links | BibTeX

16 dati « 1 di 2 »
manda un messaggio a https://t.me/@ChirurgiaFegato

Invia subito una richiesta con Telegram

Apri direttamente Telegram ed inviaci un SMS veloce e sicuro: riceverai una risposta alla tua necessità in tempi brevissimi